Néphropathie diabétique : IEC ou sartans ? CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …

Introduction L'apparition d'une néphropathie chez le diabétique marque un tournant de
gravité en termes de risque cardiovasculaire. L'hypertension artérielle est une cause …

End‐stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most
frequent cause of renal replacement therapy in western Europe. The majority of patients with …

Conclusion Cette analyse post-hoc d'une RCT ne montre pas de bénéfice de l'irbesartan par
rapport à l'amlodipine pour la prévention des événements cardiovasculaires chez les …

Diabetes is associated with a high risk of the development of cardiovascular disease and
renal disease, and in patients with microalbuminuria this risk is further increased. Inhibition …

Résumé Le diabète est aujourd'hui une cause essentielle de maladie rénale chronique
(MRC) dont les conséquences sont majeures en termes de morbi-mortalité, de dégradation …

Diabetic nephropathy (DNP) is associated with a high risk of end-stage renal failure and an
unfavorable cardiovascular prognosis, which requires strict blood pressure and glycemic …

Chronic renal diseases, including diabetic nephropathy, evolve to terminal renal failure by a
process leading to progressive parenchimal damage which appears relatively independent …

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs),
two drug classes that effectively block the actions of the renin-angiotensin system (RAS) …

The changing trajectory of diabetic kidney disease : Current Opinion in Nephrology and
Hypertension The changing trajectory of diabetic kidney disease : Current Opinion in …